Table 6.
Label | p value | Adjusted p value | In background | In set | In set/in background% |
---|---|---|---|---|---|
Metabolic pathways | 5.51E − 13 | 4.24E − 11 | 1455 | 61 | 4.2 |
Citrate cycle (TCA cycle) | 4.39E − 09 | 1.69E − 07 | 20 | 8 | 40.0 |
Pyrimidine metabolism | 4.45E − 07 | 1.14E − 05 | 59 | 10 | 16.9 |
Tyrosine metabolism | 4.99E − 06 | 8.56E − 05 | 76 | 10 | 13.2 |
Parkinson's disease | 5.56E − 06 | 8.56E − 05 | 13 | 5 | 38.5 |
Glycine, serine, and threonine metabolism | 9.36E − 06 | 1.12E − 04 | 49 | 8 | 16.3 |
Alanine, aspartate, and glutamate metabolism | 1.01E − 05 | 1.12E − 04 | 24 | 6 | 25.0 |
Oxidative phosphorylation | 1.79E − 05 | 1.64E − 04 | 16 | 5 | 31.3 |
Neuroactive ligand-receptor interaction | 1.91E − 05 | 1.64E − 04 | 128 | 15 | 11.7 |
Butanoate metabolism | 2.21E − 05 | 1.70E − 04 | 40 | 7 | 17.5 |